Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 108,000 | 65,000 | 47,000 | 2,000 | -14,000 |
| Depreciation Amortization | 15,000 | 10,000 | 5,000 | 29,000 | 19,000 |
| Income taxes - deferred | -8,000 | 7,000 | -2,000 | 6,000 | -30,000 |
| Accounts receivable | -3,000 | 15,000 | 11,000 | -1,000 | 3,000 |
| Other Working Capital | 42,000 | 139,000 | 17,000 | -41,000 | 40,000 |
| Other Operating Activity | 40,000 | -3,000 | -3,000 | 41,000 | 35,000 |
| Operating Cash Flow | $194,000 | $233,000 | $75,000 | $36,000 | $53,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,000 | -11,000 | -5,000 | -17,000 | -14,000 |
| PPE Investments | -42,000 | -22,000 | -5,000 | -29,000 | -13,000 |
| Sale Of Investment | 14,000 | 11,000 | 6,000 | 117,000 | 88,000 |
| Purchase Sale Intangibles | -1,000 | -1,000 | N/A | -2,000 | -1,000 |
| Other Investing Activity | 0 | 0 | -1,000 | -2,000 | 0 |
| Investing Cash Flow | $-42,000 | $-22,000 | $-5,000 | $69,000 | $61,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 332,000 | N/A |
| Debt Repayment | -12,000 | -8,000 | -4,000 | -240,000 | -2,000 |
| Common Stock Issued | 2,000 | 1,000 | 1,000 | 3,000 | 3,000 |
| Common Stock Repurchased | -11,000 | -11,000 | -11,000 | -173,000 | -123,000 |
| Other Financing Activity | -4,000 | -4,000 | -3,000 | -24,000 | -20,000 |
| Financing Cash Flow | $-25,000 | $-22,000 | $-17,000 | $-102,000 | $-142,000 |
| Exchange Rate Effect | -1,000 | 1,000 | N/A | N/A | -1,000 |
| Beginning Cash Position | 319,000 | 319,000 | 319,000 | 316,000 | 316,000 |
| End Cash Position | 445,000 | 510,000 | 372,000 | 319,000 | 288,000 |
| Net Cash Flow | $126,000 | $191,000 | $53,000 | $3,000 | $-28,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 194,000 | 233,000 | 75,000 | 36,000 | 53,000 |
| Capital Expenditure | -42,000 | -22,000 | -5,000 | -29,000 | -13,000 |
| Free Cash Flow | 152,000 | 211,000 | 70,000 | 7,000 | 40,000 |